PGR and endometrial polyp: The results regarding the expression of estrogen and progesterone receptors and proliferation (Ki-67) and apoptosis (Bcl-2) markers in the endometrial polyps of postmenopausal users (group 2) and nonusers of tamoxifen (group 1) are displayed in Table 1.